Synonyms: NADH dehydrogenase I subunit K, NDH-1 subunit K.
AA Sequence:
MIPLTHGLILAAILFVLGLTGLVIRRNLLFMLIGLEIMINASALAFVVAGSYWGQTDGQV MYILAISLAAAEASIGLALLLQLHRRRQNLNIDSVSEMRG .
The NDH-1 complex in Salmonella consists of:
Hydrophilic Domain: Contains subunits (e.g., NuoBC, NuoCD) with NADH-binding and electron-transfer sites.
Hydrophobic Domain: Includes seven subunits (NuoM, NuoN, NuoK, etc.) forming proton-translocating channels .
nuoK spans three transmembrane helices (TM1–3) and interacts with the cytoplasmic loop between TM1 and TM2 (loop-1). Critical residues include:
Glu-36 (TM2): Essential for proton translocation; mutation to Ala abolishes activity .
Glu-72 (TM3): Modulates activity; mutation reduces efficiency .
Arg-25/26 (loop-1): Double mutations disrupt proton pumping .
Recombinant nuoK is typically expressed in E. coli (His-tagged) or Baculovirus systems, with purification via affinity chromatography. Key parameters include:
Vaccine Development: Used as an antigen in Salmonella vaccine research .
ELISA/Diagnostics: Serves as a target in immunoassays for detecting Salmonella infections .
Structural Studies: Investigates proton translocation mechanisms and quinone interactions .
Mutations in nuoG, nuoM, and nuoN rescue respiration defects in Salmonella strains lacking ubiquinone biosynthesis (ubiA deletion):
KEGG: seh:SeHA_C2558
NADH-quinone oxidoreductase subunit K (nuoK) is a membrane protein component of Complex I in the bacterial respiratory chain. In Salmonella species, including S. heidelberg, this protein plays a crucial role in energy metabolism by participating in the electron transport chain. The protein is encoded by the nuoK gene and functions as part of the NADH dehydrogenase I complex, which is responsible for transferring electrons from NADH to quinones in the bacterial membrane . This process is fundamental to cellular respiration and ATP production in these pathogens.
The biological significance of nuoK extends beyond basic metabolism, as respiratory chain components have been implicated in bacterial pathogenesis and survival within host environments. Salmonella heidelberg is a clinically significant serotype that causes an estimated 1.35 million infections and 26,500 hospitalizations annually in the United States . Understanding the functional role of nuoK may provide insights into S. heidelberg's virulence mechanisms and metabolic adaptations during infection.
While the complete amino acid sequence of S. heidelberg nuoK is not explicitly provided in the available data, we can analyze the sequence information available for S. newport nuoK as a comparative reference. The S. newport nuoK protein consists of 100 amino acids with the following sequence:
MIPLTHGLILAAILFVLGLTGLVIRRNLLFMLIGLEIMINASALAFVVAGSYWGQTDGQVMYILAISLAAAEASIGLALLLQLHRRRQNLNIDSVSEMRG
Sequence analysis would typically reveal high conservation among Salmonella serotypes for this protein, with potential minor variations that might influence protein function or stability. Researchers investigating S. heidelberg should conduct comparative sequence analysis to identify any serotype-specific amino acid substitutions that might correlate with functional differences or antimicrobial resistance patterns. Such variations could be particularly relevant given that S. heidelberg has been associated with multidrug-resistant outbreaks .
Based on existing recombinant protein production protocols, E. coli expression systems have proven effective for producing Salmonella nuoK proteins. For the S. newport nuoK protein, successful expression has been achieved using E. coli with an N-terminal His-tag fusion . This approach enables efficient purification using affinity chromatography while maintaining protein functionality.
For S. heidelberg nuoK specifically, researchers should consider:
Expression vector selection: Vectors containing inducible promoters (such as T7) with appropriate fusion tags (His, GST, or MBP) to facilitate purification and potentially enhance solubility
E. coli strain optimization: BL21(DE3) or derivatives that lack certain proteases may improve protein yield
Induction conditions: Temperature, inducer concentration, and duration require optimization, with lower temperatures (16-25°C) often favoring proper folding of membrane proteins
Membrane protein considerations: Given that nuoK is a membrane protein, specialized approaches including detergent solubilization or membrane-mimetic systems may be necessary for maintaining native structure
When designing expression constructs, researchers should note that the full-length nuoK protein spans amino acids 1-100, which should be considered when designing primers and expression vectors .
Following purification of recombinant nuoK protein, researchers should implement multiple complementary approaches to assess both structural integrity and functional activity:
Structural verification methods:
SDS-PAGE analysis to confirm molecular weight and purity (>90% purity is typically achievable)
Circular dichroism (CD) spectroscopy to assess secondary structure elements
Mass spectrometry for molecular weight confirmation and post-translational modification analysis
Limited proteolysis to evaluate protein folding
Functional assays:
NADH oxidation activity measurements using spectrophotometric assays
Reconstitution experiments in liposomes to assess membrane integration
Electron transfer capacity using artificial electron acceptors
Binding assays with known interaction partners from the NADH dehydrogenase complex
Researchers should store the purified protein according to established protocols, which typically recommend reconstitution in deionized sterile water to a concentration of 0.1-1.0 mg/mL with 5-50% glycerol as a cryoprotectant, followed by aliquoting and storage at -20°C/-80°C to avoid repeated freeze-thaw cycles .
Multidrug-resistant (MDR) Salmonella heidelberg presents a significant public health concern, with recent outbreaks showing resistance to multiple antimicrobial classes . The potential role of nuoK in antimicrobial resistance warrants investigation from several perspectives:
Energy metabolism and efflux pump activity: As a component of the respiratory chain, nuoK contributes to energy production that powers efflux pumps responsible for expelling antibiotics from bacterial cells. Research should examine whether alterations in nuoK expression or activity correlate with enhanced efflux pump function in resistant strains.
Membrane integrity: nuoK's location in the bacterial membrane may influence membrane permeability and, consequently, antibiotic penetration. Mutations or expression changes in nuoK could potentially alter membrane characteristics that affect antimicrobial entry.
Metabolic adaptation: Changes in respiratory chain function might allow MDR strains to adapt their metabolism under antibiotic pressure, potentially enabling persistence despite antimicrobial treatment.
The multidrug-resistant Salmonella heidelberg strains identified in recent outbreaks carried resistance determinants to several antimicrobial classes, including those used as first-line treatments for severe salmonellosis (ciprofloxacin, ceftriaxone, or azithromycin) . Studies examining nuoK sequence variations or expression levels in these MDR strains compared to susceptible isolates could provide valuable insights into potential associations with resistance mechanisms.
Environmental adaptation is crucial for Salmonella pathogenesis across diverse host environments. Research questions regarding nuoK expression should address:
Host-associated environmental signals: Expression analysis under conditions mimicking the gastrointestinal tract (low pH, high osmolarity, bile salts) versus systemic infection sites (serum, macrophage phagosome)
Oxygen availability: As a respiratory chain component, nuoK expression and function likely respond to varying oxygen tensions encountered during infection (aerobic intestinal lumen versus microaerobic tissue environments)
Nutrient availability: Expression changes in response to carbon source availability, particularly host-derived nutrients
Temperature fluctuations: Comparative expression at environmental (25°C) versus host body temperatures (37°C or 42°C for avian hosts)
Experimental approaches should include:
Quantitative RT-PCR to measure transcript levels
Reporter gene fusions to monitor promoter activity in real-time
Proteomics to assess protein abundance under different conditions
In vivo expression analysis during various stages of infection
Understanding these expression patterns may provide insights into the protein's role throughout the infection cycle, particularly given that Salmonella heidelberg has been associated with invasive infections that can spread to the bloodstream and increase disease severity .
The NADH dehydrogenase complex (Complex I) is a multi-subunit enzyme composed of numerous proteins that must assemble correctly for proper function. Research into nuoK interactions should address:
Protein-protein interaction mapping: Techniques such as bacterial two-hybrid systems, co-immunoprecipitation, or crosslinking studies can identify direct interaction partners of nuoK within the complex.
Assembly dynamics: Pulse-chase experiments combined with blue native PAGE can elucidate the temporal sequence of complex assembly and the role of nuoK in this process.
Structural studies: Cryo-electron microscopy of the intact complex could reveal the precise positioning of nuoK and its contacts with neighboring subunits.
Functional consequences of disrupted interactions: Site-directed mutagenesis targeting residues at predicted interaction interfaces, followed by functional assays, can determine which interactions are crucial for enzyme activity.
Understanding the relationship between nuoK function and virulence requires systematic investigation using various experimental approaches:
Construction of defined nuoK mutants:
Complete gene deletion mutants
Point mutations affecting specific functional domains
Conditional expression systems
In vitro virulence assays:
Invasion and intracellular replication in epithelial cells and macrophages
Survival under conditions mimicking host environments (acid stress, oxidative stress)
Biofilm formation capacity
Animal infection models:
Colonization and persistence in mouse intestinal models
Systemic spread and organ burden in invasive infection models
Chicken models to assess colonization relevant to food safety
Previous research with Salmonella has shown that respiratory chain components can impact virulence through various mechanisms, including altered intracellular survival, modified motility, or changes in expression of virulence factors. Given that Salmonella heidelberg has demonstrated invasive characteristics with bloodstream infections and increased disease severity , the role of nuoK in virulence deserves particular attention.
Successfully producing recombinant Salmonella nuoK protein requires careful optimization of expression and purification conditions, considering its nature as a membrane protein:
Expression optimization table:
Purification recommendations:
Membrane extraction: Use appropriate detergents (DDM, LDAO, or Fos-Choline) to solubilize the membrane fraction containing nuoK
Affinity chromatography: Ni-NTA or similar for His-tagged proteins
Buffer optimization: Include glycerol (5-10%) and appropriate detergent at concentrations above CMC
Quality control: Assess purity by SDS-PAGE (target >90% purity)
Storage: Store in buffer containing 6% trehalose at pH 8.0 with aliquoting to avoid freeze-thaw cycles
Reconstitution of the lyophilized protein should follow established protocols using deionized sterile water to a concentration of 0.1-1.0 mg/mL, with the addition of 5-50% glycerol (final concentration) for long-term storage at -20°C/-80°C .
Investigating structure-function relationships for the nuoK protein requires an integrated approach combining structural biology techniques with functional assays:
Structural analysis approaches:
X-ray crystallography: Challenging for membrane proteins but could provide high-resolution structures
Cryo-electron microscopy: Increasingly successful for membrane protein complexes
NMR spectroscopy: Suitable for analyzing dynamics and ligand interactions
Computational modeling: Homology modeling based on related structures
Cross-linking mass spectrometry: For mapping interaction interfaces
Functional characterization methods:
Site-directed mutagenesis: Target conserved residues or those predicted to be functionally important
Electron transport assays: Measure NADH oxidation rates and coupling to quinone reduction
Proton pumping measurements: Assess proton translocation in reconstituted systems
Complementation studies: Restore function in nuoK-deficient strains with wild-type or mutant variants
Structure-function analysis workflow:
Generate structural model based on bioinformatics analysis of the nuoK sequence (100 amino acids)
Identify conserved residues and predicted functional domains
Create a panel of point mutations targeting these regions
Express and purify mutant proteins
Assess structural integrity using the methods described in section 1.4
Measure functional parameters and compare to wild-type protein
Correlate structural alterations with changes in function
This systematic approach will help identify key residues and structural elements responsible for nuoK's role in electron transport and potentially in antimicrobial resistance or virulence.
Investigating nuoK's potential contribution to antimicrobial resistance requires a multifaceted approach:
Genetic approaches:
Generate knockout or conditional mutants of nuoK in both susceptible and MDR S. heidelberg strains
Determine minimum inhibitory concentrations (MICs) of various antimicrobials for wild-type and mutant strains
Construct complemented strains to confirm phenotypic changes are specifically due to nuoK
Perform gene expression analysis to identify potential compensatory mechanisms
Biochemical and physiological approaches:
Measure membrane potential in wild-type and nuoK-mutant strains in the presence and absence of antimicrobials
Quantify intracellular accumulation of fluorescent antibiotic analogs to assess permeability or efflux
Measure ATP production to determine energy generation capacity
Assess respiratory chain activity with various electron donors/acceptors
Clinical isolate analysis:
Sequence nuoK from clinical isolates with varying resistance profiles
Correlate sequence variations with antimicrobial susceptibility patterns
Measure nuoK expression levels in resistant versus susceptible isolates
Test whether nuoK variants from resistant isolates confer resistance when introduced into susceptible strains
This research is particularly relevant given that multidrug-resistant Salmonella heidelberg strains pose a serious human health threat, with increased risk of bloodstream infections and challenging treatment options .
Developing robust immunological detection methods for nuoK requires careful consideration of this protein's characteristics as a membrane-embedded component:
Antibody development strategies:
Antigen selection:
Full-length recombinant protein (challenging due to hydrophobicity)
Extracellular or periplasmic loop peptides (more accessible)
Synthetic peptides corresponding to immunogenic epitopes
Antibody production:
Polyclonal antibodies: Broader epitope recognition but potential cross-reactivity
Monoclonal antibodies: Higher specificity but may be challenging to develop against membrane proteins
Recombinant antibody fragments: Alternative approach for difficult targets
Immunoassay development considerations:
Sample preparation protocols:
Membrane fraction isolation
Detergent solubilization optimization
Fixation methods for intact cells
Detection methods:
Western blotting (denatured protein)
Immunofluorescence microscopy (cellular localization)
Flow cytometry (quantitative analysis)
ELISA (quantification in prepared samples)
Assay validation criteria:
Specificity testing against related Salmonella serotypes
Sensitivity determination
Reproducibility assessment
Cross-reactivity evaluation
Recent research on immune responses against recombinant Salmonella proteins in chickens demonstrates the feasibility of generating specific immune responses against Salmonella antigens . While this work focused on different proteins (FliD, FlgK, FimA, and FimW), the methodological approaches could be adapted for nuoK-specific immunoassays.
The emergence of multidrug-resistant Salmonella heidelberg strains resistant to first-line antimicrobials necessitates new therapeutic approaches . Research into nuoK as a potential antimicrobial target should consider:
Target validation studies:
Essentiality assessment under various growth conditions
Impact of nuoK inhibition on bacterial fitness and virulence
Structural differences from human homologs that could be exploited for selectivity
Inhibitor development approaches:
Structure-based drug design targeting specific functional domains
High-throughput screening of chemical libraries against nuoK function
Peptide inhibitors designed to disrupt critical protein-protein interactions
Combination therapy potential:
Synergistic effects between respiratory chain inhibitors and conventional antibiotics
Sensitization of resistant strains through metabolic disruption
Delivery strategies:
Nanoparticle formulations to improve compound access to intracellular bacteria
Prodrug approaches to enhance penetration through bacterial membranes
Recent outbreaks of multidrug-resistant Salmonella heidelberg have demonstrated resistance to multiple antimicrobial classes, highlighting the urgent need for novel therapeutic approaches . Targeting essential metabolic pathways like those involving nuoK represents a promising alternative to conventional antimicrobials that are increasingly compromised by resistance mechanisms.
Exploring nuoK as a vaccine antigen candidate requires evaluation of several key aspects:
Antigenicity and immunogenicity assessment:
Epitope mapping to identify immunogenic regions
Analysis of conservation across Salmonella serotypes and strains
Evaluation in animal models for antibody and cell-mediated responses
Vaccine formulation considerations:
Subunit vaccine incorporating purified recombinant nuoK
DNA vaccines encoding the nuoK gene
Incorporation into existing attenuated live vaccine platforms
Adjuvant selection to enhance immunogenicity
Protection assessment metrics:
Reduction in colonization in animal models
Prevention of systemic spread
Antibody titers and correlation with protection
Cross-protection against heterologous strains
Practical implementation considerations:
Stability under various storage conditions
Administration routes (oral, injectable, mucosal)
Integration with existing vaccination programs
Recent research has demonstrated the feasibility of using recombinant Salmonella proteins as vaccine candidates, with successful immune responses observed in chickens against surface-exposed proteins like FliD, FlgK, FimA, and FimW . While nuoK is primarily membrane-embedded rather than surface-exposed, portions of the protein might still be accessible to the immune system or could be engineered for enhanced exposure.
Comprehensive analysis of nuoK variation requires integration of genomic and proteomic techniques:
Genomic analysis workflow:
Whole genome sequencing of diverse S. heidelberg isolates
Identification of nuoK sequence variants
Analysis of upstream regulatory regions
Assessment of gene neighborhood conservation
Detection of horizontal gene transfer events
Proteomic investigation approaches:
Quantitative proteomics to assess nuoK expression levels across strains
Post-translational modification profiling
Protein-protein interaction network mapping
Structural proteomics to detect conformational variations
Integrated analysis strategies:
Correlation of genomic variants with proteomic differences
Association of variations with phenotypic characteristics (virulence, AMR)
Evolutionary analysis to identify selection pressures
Functional impact prediction of observed variations
Data integration with existing resources:
This approach is particularly relevant given the genomic diversity observed in Salmonella heidelberg outbreak strains, which have demonstrated varied resistance profiles and virulence characteristics across different regions and time periods .
Systems biology offers powerful tools for understanding nuoK's role within the broader context of Salmonella biology:
Network analysis approaches:
Metabolic flux analysis to quantify the impact of nuoK alterations on cellular metabolism
Regulatory network reconstruction to identify factors controlling nuoK expression
Protein interaction networks to map functional relationships
Pathway enrichment analysis to identify processes affected by nuoK perturbation
Multi-omics integration strategies:
Transcriptomics-proteomics correlation during infection
Metabolomics to detect metabolic shifts in nuoK mutants
Integration of phenotypic microarray data with gene expression profiles
Host-pathogen interaction networks during infection
Mathematical modeling approaches:
Kinetic modeling of electron transport chain function
Flux balance analysis to predict metabolic consequences of nuoK perturbation
Agent-based modeling of infection dynamics
Machine learning to identify patterns in multi-omics datasets
Experimental validation methods:
CRISPR interference for targeted gene expression modulation
Metabolic labeling to track flux through specific pathways
Single-cell analyses to capture population heterogeneity
In vivo imaging to monitor infection dynamics
These approaches could help explain the mechanisms underlying the increased virulence and antimicrobial resistance observed in recent Salmonella heidelberg outbreaks, where isolates demonstrated not only multidrug resistance but also enhanced invasiveness and clinical severity .